These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37437651)

  • 41. Differential growth rates in stromal cultures of human prostate derived from patients of varying ages.
    Sensibar JA; Pruden SJ; Kasjanski RZ; Rademaker A; Lee C; Grayhack JT; Kozlowski JM
    Prostate; 1999 Feb; 38(2):110-7. PubMed ID: 9973096
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cooperative effects of EGF, FGF, and TGF-β1 in prostate stromal cells are different from responses to single growth factors.
    Hennenberg M; Schreiber A; Ciotkowska A; Rutz B; Waidelich R; Strittmatter F; Stief CG; Gratzke C
    Life Sci; 2015 Feb; 123():18-24. PubMed ID: 25529149
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prostatic osteopontin expression is associated with symptomatic benign prostatic hyperplasia.
    Popovics P; Awadallah WN; Kohrt SE; Case TC; Miller NL; Ricke EA; Huang W; Ramirez-Solano M; Liu Q; Vezina CM; Matusik RJ; Ricke WA; Grabowska MM
    Prostate; 2020 Jul; 80(10):731-741. PubMed ID: 32356572
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of neurogenic and thromboxane A
    Li B; Wang X; Wang R; Rutz B; Ciotkowska A; Gratzke C; Herlemann A; Spek A; Tamalunas A; Waidelich R; Stief CG; Hennenberg M
    Prostate; 2020 Aug; 80(11):831-849. PubMed ID: 32449814
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Protease-activated receptor-1 upregulates fibroblast growth factor 7 in stroma of benign prostatic hyperplasia.
    Wang W; Zhang X; Mize GJ; Takayama TK
    Prostate; 2008 Jul; 68(10):1064-75. PubMed ID: 18386288
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cdc42 downregulates MMP-1 expression by inhibiting the ERK1/2 pathway.
    Deroanne CF; Hamelryckx D; Ho TT; Lambert CA; Catroux P; Lapière CM; Nusgens BV
    J Cell Sci; 2005 Mar; 118(Pt 6):1173-83. PubMed ID: 15728253
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A human prostatic stromal myofibroblast cell line WPMY-1: a model for stromal-epithelial interactions in prostatic neoplasia.
    Webber MM; Trakul N; Thraves PS; Bello-DeOcampo D; Chu WW; Storto PD; Huard TK; Rhim JS; Williams DE
    Carcinogenesis; 1999 Jul; 20(7):1185-92. PubMed ID: 10383888
    [TBL] [Abstract][Full Text] [Related]  

  • 48. p21-Activated kinase (Pak) regulates airway smooth muscle contraction by regulating paxillin complexes that mediate actin polymerization.
    Zhang W; Huang Y; Gunst SJ
    J Physiol; 2016 Sep; 594(17):4879-900. PubMed ID: 27038336
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relationship between the prostatic tissue components and natural history of benign prostatic hyperplasia.
    Matsuda T; Fujime M; Suda K
    Anal Quant Cytol Histol; 2006 Jun; 28(3):121-4. PubMed ID: 16786720
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of prostatic smooth muscle contraction by the inhibitor of G protein-coupled receptor kinase 2/3, CMPD101.
    Yu Q; Gratzke C; Wang Y; Herlemann A; Strittmatter F; Rutz B; Stief CG; Hennenberg M
    Eur J Pharmacol; 2018 Jul; 831():9-19. PubMed ID: 29698717
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of LIM kinase reduces contraction and proliferation in bladder smooth muscle.
    Yu Q; Wu C; Chen Y; Li B; Wang R; Huang R; Li X; Gu D; Wang X; Duan X; Li S; Liu Y; Wu W; Hennenberg M; Zeng G
    Acta Pharm Sin B; 2021 Jul; 11(7):1914-1930. PubMed ID: 34386328
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The vitamin D receptor agonist elocalcitol inhibits IL-8-dependent benign prostatic hyperplasia stromal cell proliferation and inflammatory response by targeting the RhoA/Rho kinase and NF-kappaB pathways.
    Penna G; Fibbi B; Amuchastegui S; Corsiero E; Laverny G; Silvestrini E; Chavalmane A; Morelli A; Sarchielli E; Vannelli GB; Gacci M; Colli E; Maggi M; Adorini L
    Prostate; 2009 Apr; 69(5):480-93. PubMed ID: 19107880
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phenotypic characterization of human prostatic stromal cells in primary cultures derived from human tissue samples.
    Gravina GL; Mancini A; Ranieri G; Di Pasquale B; Marampon F; Di Clemente L; Ricevuto E; Festuccia C
    Int J Oncol; 2013 Jun; 42(6):2116-22. PubMed ID: 23589051
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Myosin heavy chain gene expression in normal and hyperplastic human prostate tissue.
    Lin VK; Wang D; Lee IL; Vasquez D; Fagelson JE; McConnell JD
    Prostate; 2000 Aug; 44(3):193-203. PubMed ID: 10906735
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Elevated epithelial expression of interleukin-8 correlates with myofibroblast reactive stroma in benign prostatic hyperplasia.
    Schauer IG; Ressler SJ; Tuxhorn JA; Dang TD; Rowley DR
    Urology; 2008 Jul; 72(1):205-13. PubMed ID: 18314176
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Rac1/Cdc42 GTPase-specific small molecule inhibitor suppresses growth of primary human prostate cancer xenografts and prolongs survival in mice.
    Zins K; Lucas T; Reichl P; Abraham D; Aharinejad S
    PLoS One; 2013; 8(9):e74924. PubMed ID: 24040362
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of smooth muscle contraction and ARF6 activity by the inhibitor for cytohesin GEFs, secinH3, in the human prostate.
    Herlemann A; Keller P; Schott M; Tamalunas A; Ciotkowska A; Rutz B; Wang Y; Yu Q; Waidelich R; Strittmatter F; Stief CG; Gratzke C; Hennenberg M
    Am J Physiol Renal Physiol; 2018 Jan; 314(1):F47-F57. PubMed ID: 28855187
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Promotion of epithelial hyperplasia by interleukin-8-CXCR axis in human prostate.
    Smith DK; Hasanali SL; Wang J; Kallifatidis G; Morera DS; Jordan AR; Terris MK; Klaassen Z; Bollag R; Lokeshwar VB; Lokeshwar BL
    Prostate; 2020 Sep; 80(12):938-949. PubMed ID: 32542667
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Epigallocatechin-3-gallate reduces the proliferation of benign prostatic hyperplasia cells via regulation of focal adhesions.
    Tepedelen BE; Soya E; Korkmaz M
    Life Sci; 2017 Dec; 191():74-81. PubMed ID: 29032114
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The STK16 inhibitor STK16-IN-1 inhibits non-adrenergic and non-neurogenic smooth muscle contractions in the human prostate and the human male detrusor.
    Li B; Wang X; Rutz B; Wang R; Tamalunas A; Strittmatter F; Waidelich R; Stief CG; Hennenberg M
    Naunyn Schmiedebergs Arch Pharmacol; 2020 May; 393(5):829-842. PubMed ID: 31867686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.